INTRODUCTION
With increasing side effects of synthetic drugs, plant derived therapeutics become more promising. Rising demand of plant-based medicines necessitates screening of their bioactive constituents for novel compounds of therapeutic importance. A detailed literature review on the plant under investigation has shown that so far, there are no published reports on the chemical components of different parts of R. emodi other than the rhizome. The present study focuses on chemical characterization of the important Himalayan herb viz., R. emodi for isolation and identification of its important chemical constituents from both conventionally used part i.e., rhizome as well as other parts of the plant.
MATERIALS AND METHODS

Collection of Plant samples
The plant material (Rhizome and fruits) of R. emodi was collected from Bagheswar district (29º51'0"N 79º46'0"E, 1,004m) of Uttarakhand in the month of March, 2016. Rhizomes were grown under controlled environment facility available in College of Basic Sciences and Humanities, G.B. Pant University of Agriculture and Technology, Pantnagar, for further studies.
Leaf explants obtained from the pot grown plants (3 months old) were surface sterilised with 1% bavistin and 0.1 % HgCl 2 and inoculated on Murashige and Skoog medium supplemented with 3% sucrose, 5.0 µM NAA, 10.0 µM BAP and 0.8 % agar. Inoculated explants were placed in culture room with 16 h photoperiod supplied by cool white fluorescent tube lights at 25 ± 2ºC for callus induction. 30 days harvested callus was used for sample preparation.
Preparation of crude extract
The plant samples (Rhizomes, fruits, leaves and callus) were air dried at room temperature and grinded separately to fine powder. 2g fine powder of each sample was subjected to extraction in 250 ml of methanol using Soxhlet apparatus (Khera Instruments Pvt. Ltd., Delhi, India). The methanol extract was evaporated in a rotary evaporator (U-Tech, Star Scientific Instruments, Delhi, India) at 70ºC to obtain solid mass. The solid mass was collected and stored at 4ºC for further use. The extracted samples was redissolved in methanol for GC-MS analysis.
GC-MS analysis
The Gas Chromatography-Mass Spectroscopic (GC-MS) analysis of methanol extract was performed by using GC-MS (QP2010 Plus, Gas Chromatograph Mass spectrometer, SHIMADZU, USA.) equipped with Rxi ®-5Sil MS capillary GC column (5% phenyl 95% dimethyl polysiloxane) with 30 m length, 0.25mm dia. and 0.25µm film thickness. Flow rate of mobile phase (Carrier gas: He) was set at 1.21 ml/min. Temperature (Oven temperature) was set at 80ºC subsequently raised to 250ºC at 5ºC/min and injected with 1µl volume. Samples dissolved in methanol were run fully at range of 40-700 m/z.
Identification of compounds
The bioactive compounds obtained by GC-MS were identified after matching their mass fragmentation pattern with data available in GC-MS library of National Institute of Standards Technology (NIST) and Wiley Registry of Mass Spectral Data's, New York (Wiley). The relative percentage of each constituent was expressed as percentage with peak area normalization.
RESULTS AND DISCUSSION
The gas chromatograms of rhizome, leaf, fruit and callus of R. emodi confirmed the existence of numerous interesting compounds with different retention times. The compounds were identified through mass spectrometry attached with GC. The identified compounds and their molecular formula, molecular weight, peak area (%) are given in Table 1 ; nature of the compounds and their biological activities are given in Table 2 . Overall, 95 bioactive compounds were obtained in methanol extract of different parts of R. emodi out of which rhizome, fruits, leaf and callus extracts revealed 31, 38, 27 and 47 peaks respectively. The GC-MS chromatograms of rhizome, fruits, leaves and callus are shown in Figure 1-4 . Some of these compounds are unique to a specific plant part while others occurred as common compounds as shown by venn diagram in Figure 5 . There are only 2 compounds that are common to all extracts whereas rhizome, fruits, leaf and callus possessed 09, 16, 16 and 18 unique compounds respectively. 16 compounds were common in rhizome and callus. In fruit and callus, 15 compounds were similar whereas in fruit and rhizome 14 compounds were common. Leaf and callus, however showed only 10 common compounds. Rhizome, fruit and leaf showed only one common compound viz., myristyl palmitate whereas rhizome, leaf and callus extracts showed methyl palmitate as a common compound. and Stigmasta-3,5-dien-7-one(1.13) are the major compounds of the callus extract. GC-MS analysis of crude extracts of different parts of R. emodi revealed presence of several bioactive compounds having strong biological activities such as antibacterial, antifungal, anti-inflammatory, antidiabetic, anticancerous and other prophylactic activities. Besides, the different extracts showed presence of several important anthraquinones like Chrysophanol and Physcion that are known to possess anticancer activity. The other anticancer compounds present in the extracts are 9-Octadecenoic acid(Z)-, methyl ester, Diosgenin, 7, beta-Hydroxydiosgenin, Lupeol and Pyrogallol. γ-sitosterol, β-sitosterol and Diosgenin are the important anti-diabetic compounds reported in the extracts. Lupeol, Neophytadiene, Stigmasta-3, 5-dien-7-one are anti-inflammatory compounds whereas Squalene, Vitamin E, Hexadecanoic acid, methyl ester are antimicrobial compounds reported in the extract (Table 2) . Squalene, an important triterpene having antioxidant, immunostimulatory and anticancer properties was found in all the extracts of R. emodi except rhizome with maximum area in leaf (3.21%). Present study revealed that leaf of R. emodi can also be used as a potential source of diosgenin as rhizome, leaf and callus possessed 2.65%, 6.84% and 2.14% diosgenin respectively. Conventionally, diosgenin is obtained mainly from Dioscorea sp. 37 and is used in pharmaceutical industries for preparing various steroidal drugs against cancer, inflammation, hypercholesterolemia and several types of infections. γ-sitosterol, an important antidiabetic compound was also obtained in fruit (3.77%) and callus (9.86%) extracts of R. emodi. The present study reports for first time, the presence of important anticancerous compounds viz., pyrogallol (3.84%) and physcion (4.66%) in fruits of the plant. Squalene, diosgenin, γ-sitosterol, pyrogallol and physcion are reported imperative anticancerous and antidiabetic compounds that are found to be present in nonconventional parts of R. emodi rather than the conventionally used rhizome. Hence, other parts of the plant can also be used for medicinal purpose relinquishing the dependence on underground rhizome.
CONCLUSION
R. emodi is an important medicinal plant showing presence of several anticancer and antidiabetic compounds. R. emodi possess plethora of anthraquinones. Physcion, an important anticancer anthraquinone till now reported only in rhizome of R. emodi was also present in the fruits. Along with the anthraquinones, other secondary metabolites viz., fatty acids, triterpenes, phytosterols, steroids, phenols, essentials oils were also present in different parts of R. emodi. These secondary metabolites are known to possess anticancerous, anti-diabetic, anti-inflammatory, antimicrobial properties. Presence of diosgenin in rhizome, leaf and callus of R. emodi indicates that these parts of the plant as well as in vitro grown callus can be used as an alternative source of this important anticancerous and antidiabetic compound. The findings of the present study provide complete GC-MS profile of the plant giving possible alternative sources of important bioactive compounds supplementing nutritional and pharmaceutical applications of the plant. 
